Technology: CAR-T therapy, Cell-based gene therapy
Industry: Public
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2021-01-01
Employees Number: 251-500
Funding Status: IPO
Investors Number: 15
Total Funding: 315000000
Last Funding Date: 2023-02-28
Last Funding Type: Post-IPO Equity

Visit Website
info@2seventybio.com
https://twitter.com/2seventybio
Register and Claim Ownership